Target intelligence / Profile preview

RNA, U6 small nuclear 763, pseudogene (RNU6-763P)

Target
RNU6-763P
Molecular classification
Other, small nuclear RNA pseudogene
01

Overview

RNU6-763P is a pseudogene derived from the U6 small nuclear RNA gene family. The functional U6 small nuclear RNA (U6 snRNA) is an essential component of the spliceosome machinery responsible for pre-mRNA splicing in eukaryotes[1][3]. Multiple copies and pseudogenes of U6 snRNA genes are commonly found in vertebrate genomes and are generally considered nonfunctional “backup” sequences preserved through evolution[1]. As a pseudogene, RNU6-763P is not transcribed and/or functional in RNA splicing; it does not produce a protein nor encode a receptor, enzyme, or therapeutic molecular target. While some pseudogenes may have regulatory effects by acting as miRNA sponges or influencing gene expression, there is no established evidence that RNU6-763P has such a function[2][4]. Thus, it is not considered a therapeutic target, nor does it have specific molecular, biological, disease, or pharmacological relevance. \nThere is nothing therapeutically actionable, nor functionally unique about RNU6-763P. There is also no current evidence it serves as a research or clinical biomarker, nor does it have reported safety concerns. \n*Note on correctness:*\nRNU6-763P is not a valid therapeutic target. It is a pseudogene, not an active receptor, enzyme, or molecular target for drugs. The name is not misspelled and refers accurately to a U6 snRNA pseudogene, but it is unlikely to be actionable or relevant for therapeutic targeting. If you intended to refer to functional U6 snRNA, that is a distinct and essential non-coding RNA molecule involved in splicing, not this pseudogene[1][3].

Other names
RNU6-763PRNA, U6 small nuclear 763, pseudogeneU6 snRNA pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U6 small nuclear 763, pseudogene (RNU6-763P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 763, pseudogene (RNU6-763P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call